Feasibility and Safety of Laparoscopic Surgery for Obese Korean Women with Endometrial Cancer: Long-Term Results at a Single Institution

Journal of Korean Medical Science 2014³â 29±Ç 11È£ p.1536 ~ p.1543

¹é¹ÎÇö(Baek Min-Hyun) - University of Ulsan College of Medicine Asan Medical Center Department of Obstetrics and Gynecology
À̽ÅÈ­(Lee Shin-Wha) - University of Ulsan College of Medicine Asan Medical Center Department of Obstetrics and Gynecology
¹ÚÁ¤¿­(Park Jeong-Yeol) - University of Ulsan College of Medicine Asan Medical Center Department of Obstetrics and Gynecology
±è´ë¿¬(Kim Dae-Yeon) - University of Ulsan College of Medicine Asan Medical Center Department of Obstetrics and Gynecology
±èÁ¾Çõ(Kim Jong-Hyeok) - University of Ulsan College of Medicine Asan Medical Center Department of Obstetrics and Gynecology
±è¿ë¸¸(Kim Yong-Man) - University of Ulsan College of Medicine Asan Medical Center Department of Obstetrics and Gynecology
±è¿µÅ¹(Kim Young-Tak) - University of Ulsan College of Medicine Asan Medical Center Department of Obstetrics and Gynecology
³²ÁÖÇö(Nam Joo-Hyun) - University of Ulsan College of Medicine Asan Medical Center Department of Obstetrics and Gynecology

Abstract

The purpose of this study was to evaluate the surgical feasibility of and survival outcome after laparoscopy in obese Korean women with endometrial cancer which has recently been increasing. We reviewed the medical records of the patients treated at our medical institution between 1999 and 2012. The patients were divided into three groups, non-obese (Body Mass Index [BMI]<25.0), overweight (BMI 25-27.99), and obese (BMI¡Ã28.0). These patient groups were compared in terms of their clinical characteristics, treatment methods, as well as surgical and survival outcomes. In total, 55 of the 278 eligible patients were obese women. There were no differences in the three groups in terms of the proportion of patients who underwent lymphadenectomy, their cancer stage, histologic type, type of adjuvant treatment administered, intra-, post-operative, and long-term complications, operative time, number of removed lymph nodes, blood loss, and duration of hospitalization (P=0.067, 0.435, 0.757, 0.739, 0.458, 0.173, 0.076, 0.124, 0.770, 0.739, and 0.831, respectively). The Disease-Free Survival (DFS) times were 139.1 vs. 121.6 vs. 135.5 months (P=0.313), and the Overall Survival (OS) times were 145.2 vs. 124.8 vs. 139.5 months (P=0.436) for each group, respectively. Obese women with endometrial cancer can, therefore, be as safely managed using laparoscopy as women with normal BMIs.

Å°¿öµå

Endometrial Neoplasms, Obesity, Laparoscopy, Surgical Outcome, Survival Outcome
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
There were no significant differences from our study in terms of the disease-free and overall survival rates in our three patient groups.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå